STOCKHOLM, Jan. 4, 2018 /PRNewswire/ — Nuevolution AB (publ) (NUE.ST) today announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has exercised its option to license one of the research programs under the multi-target collaboration entered between…

Source: https://www.prnewswire.com/news-releases/nuevolution-to-receive-license-fee-payment-of-usd-750000-300577473.html

This entry was posted on Thursday, January 4th, 2018 at 1:50 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.